Multimeric anti-OX40 cross-linking agonist antibody (IGM Biosciences)

N/A

Report date: 2025/01/26 16:19:56

Base Information

Drug NameMultimeric anti-OX40 cross-linking agonist antibody (IGM Biosciences)

Drug Alias NameOX40 costimulator (IGM Biosciences)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody

Mechanisms of ActionTumor necrosis factor receptor superfamily member 4 agonists

TargetsTumor necrosis factor receptor superfamily member 4

Therapy Area/IndicationsSolid tumoursHematologic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesIgm Biosciences Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsSolid tumoursHematologic Neoplasms

Inactive IndicationsN/A

ATC CodeN/A